Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Fellow, Harvard University Alley-Sheridan School of Government
Residency, Texas Heart Institute
Active Clinical Trials

PERIGON Pivotal Trial

NCT02088554


CoreValve High Risk Surgical Patients

NCT01240902

Publications

Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply
Popma, JJ & Reardon, MJ 2019, The New England journal of medicine, vol. 381, no. 7. https://doi.org/10.1056/NEJMc1908500

Commentary: Chronic thromboembolic pulmonary hypertension in Austria and Japan: The Sound of Music meets Madame Butterfly
Lin, CH & Reardon, MJ 2019, Journal of Thoracic and Cardiovascular Surgery, vol. 158, no. 2, pp. 615-616. https://doi.org/10.1016/j.jtcvs.2019.01.080

A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve–guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease
Zimmermann, FM, De Bruyne, B, Pijls, NHJ, Desai, M, Oldroyd, KG, Reardon, MJ, Wendler, O, Woo, J, Yeung, AC & Fearon, WF 2019, American Heart Journal, vol. 214, pp. 156-157. https://doi.org/10.1016/j.ahj.2019.04.012

Lightning striking twice: Redo mitral valve replacement due to recurrent cardiac sarcoma using partial autotransplantation technique
Al-Sabeq, B, Shen, S, Reardon, MJ & Nabi, F 2019, Journal of Thoracic and Cardiovascular Surgery, vol. 158, no. 1, pp. e1-e4. https://doi.org/10.1016/j.jtcvs.2019.01.096

Comparison of Outcomes after Transcatheter vs Surgical Aortic Valve Replacement among Patients at Intermediate Operative Risk with a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial
Reardon, MJ, Heijmen, RH, Van Mieghem, NM, Williams, MR, Yakubov, SJ, Watson, D, Kleiman, N, Conte, J, Chawla, A, Hockmuth, D, Petrossian, G, Robinson, N, Kappetein, AP, Li, S & Popma, JJ 2019, JAMA Cardiology. https://doi.org/10.1001/jamacardio.2019.1856

Bicuspid aortic valve stenosis: Is there a role for tavr?
Barker, CM & Reardon, MJ 2019, JAMA - Journal of the American Medical Association, vol. 321, no. 22, pp. 2170-2171. https://doi.org/10.1001/jama.2019.7078

The train has left: Can surgeons still get a ticket to treat structural heart disease?
Nguyen, TC, Tang, GHL, Nguyen, S, Forcillo, J, George, I, Kaneko, T, Thourani, VH, Bavaria, JE, Cheung, AW, Reardon, MJ & Mack, MJ 2019, Journal of Thoracic and Cardiovascular Surgery, vol. 157, no. 6, pp. 2369-2376.e2. https://doi.org/10.1016/j.jtcvs.2019.01.011

A Job Well Begun Is Half Done
Atkins, MD & Reardon, MJ 2019, Seminars in Thoracic and Cardiovascular Surgery. https://doi.org/10.1053/j.semtcvs.2019.02.017

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
Popma, JJ, Deeb, GM, Yakubov, SJ, Mumtaz, M, Gada, H, O’Hair, D, Bajwa, T, Heiser, JC, Merhi, W, Kleiman, NS, Askew, J, Sorajja, P, Rovin, J, Chetcuti, SJ, Adams, DH, Teirstein, PS, Zorn, GL, Forrest, JK, Tchétché, D, Resar, J, Walton, A, Piazza, N, Ramlawi, B, Robinson, N, Petrossian, G, Gleason, TG, Oh, JK, Boulware, MJ, Qiao, H, Mugglin, AS & Reardon, MJ 2019, New England Journal of Medicine, vol. 380, no. 18, pp. 1706-1715. https://doi.org/10.1056/NEJMoa1816885

C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial
Kosmidou, I, Redfors, B, Chen, S, Crowley, A, Lembo, NJ, Karmpaliotis, D, Brown, WM, Maupas, E, Durrleman, N, Shah, AR, Reardon, MJ, Dressler, O, Ben-Yehuda, O, Kappetein, AP, Sabik, JF, Serruys, PW & Stone, GW 2019, American Heart Journal, vol. 210, pp. 49-57. https://doi.org/10.1016/j.ahj.2018.12.013

Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch
Head, SJ, Reardon, MJ, Deeb, GM, Van Mieghem, NM, Popma, JJ, Gleason, TG, Williams, MR, Radhakrishnan, S, Fremes, S, Oh, JK, Chang, Y, Boulware, MJ & Kappetein, AP 2019, Circulation. Cardiovascular interventions, vol. 12, no. 4, pp. e007396. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007396

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve
Beg, F, Dadu, RT, Reardon, MJ, Little, SH, Kleiman, N & Barker, CM 2019, Methodist DeBakey cardiovascular journal, vol. 15, no. 2, pp. 149-151. https://doi.org/10.14797/mdcj-15-2-149

Is Transcarotid an “Alternative” Access?
Reardon, MJ & Barker, CM 2019, JACC: Cardiovascular Interventions, vol. 12, no. 5, pp. 420-421. https://doi.org/10.1016/j.jcin.2018.11.022

Two-Year Outcomes after Transcatheter Aortic Valve Replacement with Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial
Reardon, MJ, Feldman, TE, Meduri, CU, Makkar, RR, OHair, D, Linke, A, Kereiakes, DJ, Waksman, R, Babliaros, V, Stoler, RC, Mishkel, GJ, Rizik, DG, Iyer, VS, Gleason, TG, Tchétché, D, Rovin, JD, Lhermusier, T, Carrié, D, Hodson, RW, Allocco, DJ, Meredith, IT & Investigators, RIII 2019, JAMA Cardiology, vol. 4, no. 3, pp. 223-229. https://doi.org/10.1001/jamacardio.2019.0091

See one, do one, teach one?
Reardon, MJ 2019, The Journal of thoracic and cardiovascular surgery, vol. 157, no. 2, pp. e45-e46. https://doi.org/10.1016/j.jtcvs.2018.08.022

Frailty and clinical outcomes in chronic obstructive pulmonary disease
NETT Research Group 2019, Annals of the American Thoracic Society, vol. 16, no. 2, pp. 217-224. https://doi.org/10.1513/AnnalsATS.201803-175OC

Minimally Invasive Surgical Aortic Valve Replacement Through a Right Anterior Thoracotomy: How I Teach It
Ramchandani, MK, Wyler von Ballmoos, MC & Reardon, MJ 2019, Annals of Thoracic Surgery, vol. 107, no. 1, pp. 19-23. https://doi.org/10.1016/j.athoracsur.2018.11.006

Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis
Chetcuti, SJ, Deeb, GM, Popma, JJ, Yakubov, SJ, Grossman, PM, Patel, HJ, Casale, A, Dauerman, HL, Resar, JR, Boulware, MJ, Dries-Devlin, JL, Li, S, Oh, JK & Reardon, MJ 2019, JACC: Cardiovascular Imaging, vol. 12, no. 1, pp. 67-80. https://doi.org/10.1016/j.jcmg.2018.07.028

Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial
SURTAVI Trial Causes of Death Working Group 2019, Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2018.11.129

TAVR for Bicuspid Aortic Valves: Past Is Prologue or Tempest in a Teapot?
Barker, CM & Reardon, MJ 2019, Cardiovascular Revascularization Medicine, vol. 20, no. 1, pp. 5. https://doi.org/10.1016/j.carrev.2018.11.025

Live Chat Available